Jnana Therapeutics to Participate in Upcoming Investor Conferences
BOSTON--(BUSINESS WIRE)-- Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, today announced that management will participate in the following upcoming investor conferences:
- Cowen 43rd Annual Health Care Conference, March 6-8, 2023. Boston Management will participate in one-on-one meetings.
- Oppenheimer 33rd Annual Healthcare Conference, March 13-15, 2023 (Virtual). Joanne Kotz, Ph.D., Co-Founder and CEO, will present a company overview at 2:00 p.m. ET on March 15. Management will also participate in one-on-one meetings.
About Jnana Therapeutics
Jnana Therapeutics is a clinical-stage biotechnology company leveraging its next-generation RAPID chemoproteomics platform to discover medicines for highly validated, challenging-to-drug targets to treat diseases with high unmet need. Jnana is focused on developing first- and best-in-class therapies to treat a wide range of diseases, including rare diseases, immune-mediated diseases and cancer. Jnana’s wholly owned lead program, JNT-517, which targets an allosteric site on the phenylalanine transporter SLC6A19, is a potential first-in-class oral approach for the treatment of phenylketonuria (PKU), a rare genetic metabolic disease. Located in Boston, Jnana brings together scientific leaders in small molecule drug discovery and development, a highly experienced management team, and the backing of leading life science investors Bain Capital Life Sciences, RA Capital Management, Polaris Partners, Versant Ventures, Avalon Ventures, Pfizer Ventures, and AbbVie Ventures. For more information, please visit www.jnanatx.com and follow us on Twitter and on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230301005135/en/
Investors
Josh Rappaport
Stern Investor Relations, Inc.
[email protected]
Media
Michele Rozen
Scient PR
[email protected]
Source: Jnana Therapeutics
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aster Guardians Global Nursing Award 2026 Names Agimol Pradeep From United Kingdom Winner of USD 250,000 Prize
- Sean Kirtz and Lady Hammers Earn 3rd Place at Midwest Nationals
- 7 Best Cryptos in 2026 to Watch: Apeing’s Crypto Presale Making Headlines With Over $80K Raised
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Bain Capital, Twitter, Cowen & Co, RA CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share